AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 SEP 2 - (NewsRx.com & NewsRx.net) -- University of Washington associate professor of pharmacy Mary Hebert and her team of researchers have received a $2.8 million grant from the U.S. National Institute of Child Health and Human Development (NICHD) to research the clinical pharmacology of drugs in pregnant woman.
The UW Obstetric Fetal Pharmacology Unit includes Hebert; Jashvant Unadkat, professor of pharmaceutics; Thomas Easterling, professor of obstetrics and gynecology; and Paolo Vicini, associate professor of bioengineering.
The UW team joins three other grant recipients (Georgetown University, University of Pittsburgh, and University of Texas, Galveston) in beginning to decipher why drugs are handled differently in pregnant women compared to postpartum women, as well as what the implications are for the mother and fetus.
Hebert and the other lead scientists for the four centers will meet to determine what issues are most important and to develop a scientific strategy for studying drugs in pregnancy over the next 5 years. Clinical studies should begin later in 2004.
"In the drug development arena, ...